4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064918
Chief R&D Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zalevsky Jonathan · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-18 | Grant or award : show line 1 in the form | +40,000 | 290,317 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-18 | Grant or award : show line 2 in the form Stock Option | +71,500 | 71,500 | D |
Loading xslF345X03/doc4.xml…